Uncategorized – Page 2 – Policy & Medicine

FDA Issues Notice on Implementation of Genus Decision

Policy and Medicine Compliance Update — September 2021 Issue Reviews State Pricing Policies, Sakler Settlement, Compliance via Faith, DOJ’s Focus on Telemedicine

August 2021 Issue P&M Compliance Update features interview with Creator of California AB-1278 Open Payments Transparency Bill

Medicare Hospital Inpatient Proposed Payment Rule Calls for Additional Price Transparency

CMS Suspends Advance Payment Program

FDA OPDP Issues Warning Letter to Metuchen Pharma About ED Drug Advertising

HHS OIG Publishes Semiannual Report to Congress Detailing Efforts to Combat Fraud and Abuse & $800 million in potential savings

Bipartisan Bill Likely to Be Drafted and Introduced to Lower Prescription Drug Costs

Trump Signs Executive Order Focused on Health Care Transparency

SCOTUS Rules Judge Should Decide Merck Labeling Case